Pittsburgh, PA, United States of America

Xianonan Han


Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2008

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Xianonan Han: Innovator in Inflammatory Condition Treatments

Introduction

Xianonan Han is a prominent inventor based in Pittsburgh, PA (US). He has made significant contributions to the field of medicine, particularly in the treatment of inflammatory conditions. His innovative approach focuses on utilizing NAD-related compounds to address various inflammatory issues.

Latest Patents

Xianonan Han holds 1 patent that details a method for the prophylaxis or treatment of inflammatory conditions. This patent specifically addresses intestinal epithelial inflammation caused by conditions such as Crohn's disease or ulcerative colitis, as well as systemic causes of inflammation like endotoxemia and sepsis. The method involves administering a therapeutically effective amount of a composition that includes an NAD-related compound, which is delivered in a pharmaceutically acceptable carrier vehicle. The patent also outlines ex vivo and in vivo assay methods to test candidate compounds for activity, along with kits and articles of manufacture for therapeutic use.

Career Highlights

Xianonan Han is affiliated with the University of Pittsburgh, where he continues to advance research in his field. His work has garnered attention for its potential to improve treatment options for patients suffering from inflammatory conditions.

Collaborations

Xianonan Han has collaborated with notable colleagues, including Mitchell P. Fink and Russell L. Delude. These partnerships have contributed to the development and refinement of his innovative methods.

Conclusion

Xianonan Han's contributions to the treatment of inflammatory conditions highlight his role as a key innovator in the medical field. His work not only addresses critical health issues but also paves the way for future advancements in therapeutic methods.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…